These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 898128)

  • 41. Use of scanning electron microscopy to study structural-functional relationships in normal and diseased platelets.
    Mattson JC
    Scan Electron Microsc; 1985; (Pt 1):357-91. PubMed ID: 3890145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of platelet aggregation by novel benzoylpyrrole derivatives.
    Kurozumi S; Ohtsu A; Hoshina K; Jimba M; Komoriya K; Naruchi T; Wakabayashi T; Hashimoto Y; Ishimoto S
    Adv Prostaglandin Thromboxane Res; 1980; 6():305-7. PubMed ID: 7386272
    [No Abstract]   [Full Text] [Related]  

  • 43. Is the platelet defect in Bartter's syndrome associated with a plasma prostaglandin?
    MacIntyre DE; Smith M; Levine L; Stoff JS; Stemerman M; Steer ML; Salzman EW; Brown RS
    Adv Prostaglandin Thromboxane Res; 1980; 7():1199-202. PubMed ID: 7369031
    [No Abstract]   [Full Text] [Related]  

  • 44. Structure and "in vitro" functions of platelets stored as platelet concentrates at room temperature.
    Balduini CL; Sinigaglia F; Grignani G; Bisio A; Rota Scalabrini D; Mazzucco M; Pacchiarini L; Balduini C
    Haematologica; 1986; 71(3):177-82. PubMed ID: 3093319
    [No Abstract]   [Full Text] [Related]  

  • 45. Localization and translocation of MMP-2 during aggregation of human platelets.
    Sawicki G; Sanders EJ; Salas E; Wozniak M; Rodrigo J; Radomski MW
    Thromb Haemost; 1998 Nov; 80(5):836-9. PubMed ID: 9843180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of spontaneous platelet aggregation in whole blood with platelet rich plasma: additional evidence for the role of ADP.
    Saniabadi AR; Lowe GD; Barbenel JC; Forbes CD
    Thromb Haemost; 1984 Feb; 51(1):115-8. PubMed ID: 6719381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Platelet aggregability in apparently healthy humans of different ages].
    Kirichuk VF; Voskoboĭ IV
    Fiziol Cheloveka; 2006; 32(4):116-20. PubMed ID: 16910082
    [No Abstract]   [Full Text] [Related]  

  • 48. Platelet activation: role of an ADP receptor.
    Colman RW
    Semin Hematol; 1986 Apr; 23(2):119-28. PubMed ID: 3010469
    [No Abstract]   [Full Text] [Related]  

  • 49. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of nonresponsiveness to epinephrine in platelets from healthy humans.
    Choi JW
    Acta Haematol; 2002; 108(2):106-8. PubMed ID: 12187031
    [No Abstract]   [Full Text] [Related]  

  • 51. The function of monkey (M. mulatta) platelets compared to platelets of pig, sheep, and man.
    Addonizio VP; Edmunds LH; Colman RW
    J Lab Clin Med; 1978 Jun; 91(6):989-97. PubMed ID: 418128
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of an alpha-blocking agent, nicergoline, on the interaction between blood platelets, elastin and endothelial cells.
    Rafelson ME; Migne J; Santonja R; Derouette JC; Robert L
    Biochem Pharmacol; 1980 Mar; 29(6):943-7. PubMed ID: 7387709
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyperosmolality: a factor in ethanol-related platelet dysfunction?
    Cowan DH; Graham RC; Shook P
    Semin Hematol; 1976 Apr; 13(2):103-14. PubMed ID: 935886
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of halofenate and clofibrate on aggregation and release of serotonin by human platelets.
    Lin CY; Smith S
    Life Sci; 1976 Mar; 18(6):563-8. PubMed ID: 1263738
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene on human blood platelet structural physiology.
    Lasslo A; White JG
    Biochim Biophys Acta; 1984 Oct; 777(1):37-40. PubMed ID: 6435673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A review of pharmacological studies on nicergoline].
    Moretti A; Arcari G; Pegrassi L
    Arzneimittelforschung; 1979; 29(8a):1223-7. PubMed ID: 44197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet antiaggregating activity of imolamine: in vitro studies.
    Tremoli E; Maderna P; Cocuzza E; Mantero O
    Pharmacol Res Commun; 1979 Jan; 11(1):31-8. PubMed ID: 424437
    [No Abstract]   [Full Text] [Related]  

  • 58. Thrombocytopenic purpura with giant platelets and ultrastructural platelet defects.
    Vizcaíno GJ; Diez-Ewald M
    Am J Hematol; 1983 Aug; 15(1):89-95. PubMed ID: 6683927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human platelet aggregation by phospholipase-A.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Thromb Res; 1976 Oct; 9(4):335-44. PubMed ID: 982355
    [No Abstract]   [Full Text] [Related]  

  • 60. Mitoxantrone and bisantrene inhibition of platelet aggregation and prostaglandin E2 production in vitro.
    Frank P; Novak RF
    Biochem Pharmacol; 1985 Oct; 34(19):3609-14. PubMed ID: 3863620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.